Clinical Trial Update: P4O2 ILD Extension

View source ↗

Summary

A clinical trial update describes an extension of the P4O2 interstitial lung disease study led by Amsterdam UMC (VUmc) and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Connective Tissue Disease-associated Interstitial Lung Disease
• Hypersensitivity Pneumonitis
• Idiopathic Interstitial Pneumonia
• Idiopathic Nonspecific Interstitial Pneumonia
• Idiopathic Pulmonary Fibrosis
• Interstitial Lung Disease
• Pulmonary Fibrosis
• Unclassifiable Interstitial Lung Disease

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Interstitial Lung Disease, Pulmonary Fibrosis | Status: RECRUITING